Ming Ding

2.5k total citations
59 papers, 1.9k citations indexed

About

Ming Ding is a scholar working on Molecular Biology, Biotechnology and Biomedical Engineering. According to data from OpenAlex, Ming Ding has authored 59 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 12 papers in Biotechnology and 10 papers in Biomedical Engineering. Recurrent topics in Ming Ding's work include Enzyme Production and Characterization (10 papers), Biofuel production and bioconversion (10 papers) and interferon and immune responses (5 papers). Ming Ding is often cited by papers focused on Enzyme Production and Characterization (10 papers), Biofuel production and bioconversion (10 papers) and interferon and immune responses (5 papers). Ming Ding collaborates with scholars based in China, United States and Russia. Ming Ding's co-authors include Yonghao Yu, Yajie Zhang, Fukun Zhao, Jianqi Wang, Gen-Jun Xu, Steven L. McKnight, Siheng Xiang, Yi Lin, Masato Kato and Leeju C. Wu and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ming Ding

58 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Ding China 23 1.1k 351 252 213 185 59 1.9k
Jörg Piontek Germany 34 1.7k 1.5× 453 1.3× 154 0.6× 186 0.9× 51 0.3× 67 3.5k
Vincent S. Tagliabracci United States 25 2.1k 1.9× 225 0.6× 261 1.0× 57 0.3× 107 0.6× 51 4.0k
Doo‐Sik Kim South Korea 30 1.3k 1.2× 221 0.6× 545 2.2× 88 0.4× 128 0.7× 84 2.4k
Eugene W. Krueger United States 27 2.5k 2.2× 235 0.7× 228 0.9× 171 0.8× 76 0.4× 42 4.2k
Nazanine Modjtahedi France 24 1.6k 1.5× 629 1.8× 483 1.9× 64 0.3× 78 0.4× 45 2.6k
Feng Gu China 28 2.6k 2.3× 198 0.6× 259 1.0× 154 0.7× 39 0.2× 123 4.0k
Carol Murphy Greece 28 2.1k 1.9× 307 0.9× 315 1.3× 95 0.4× 37 0.2× 57 3.5k
Fred Levine United States 35 1.7k 1.5× 232 0.7× 434 1.7× 126 0.6× 114 0.6× 101 4.0k
Ralph Bradshaw United States 29 1.8k 1.6× 533 1.5× 234 0.9× 52 0.2× 104 0.6× 78 2.9k
Yuanyuan Ma China 30 1.2k 1.1× 549 1.6× 247 1.0× 91 0.4× 56 0.3× 109 2.3k

Countries citing papers authored by Ming Ding

Since Specialization
Citations

This map shows the geographic impact of Ming Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Ding more than expected).

Fields of papers citing papers by Ming Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Ding. The network helps show where Ming Ding may publish in the future.

Co-authorship network of co-authors of Ming Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Ding. A scholar is included among the top collaborators of Ming Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Ding. Ming Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qiang, Ying Zhang, Yuanyuan Zhang, et al.. (2025). Triflupromazine and tranylcypromine alleviate primary cisplatin resistance in lung adenocarcinoma by promoting LDHA-mediated AMBRA1 ubiquitination. Biochemical Pharmacology. 239. 117073–117073. 1 indexed citations
2.
Sun, Liangdong, Jue Wang, Huansha Yu, et al.. (2025). Selective inhibition of TGF-β-induced epithelial-mesenchymal transition overcomes chemotherapy resistance in high-risk lung squamous cell carcinoma. Communications Biology. 8(1). 152–152. 1 indexed citations
3.
4.
Zhou, Licheng, Yu‐Sun Chang, Rahul Mannan, et al.. (2024). Discovery of ZLC491 as a Potent, Selective, and Orally Bioavailable CDK12/13 PROTAC Degrader. Journal of Medicinal Chemistry. 67(20). 18247–18264. 8 indexed citations
5.
Li, Chungen, Yihan Chen, Weixue Huang, et al.. (2024). Structure-Based Design of “Head-to-Tail” Macrocyclic PROTACs. SHILAP Revista de lepidopterología. 4(12). 4866–4882. 8 indexed citations
6.
Tian, Xiao, Zhiyuan Zhang, & Ming Ding. (2023). TXLNA enhances TBK1 phosphorylation by suppressing PPM1B recruitment. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1870(7). 119550–119550. 1 indexed citations
7.
Cui, Shufang, Lei Chu, Ye Cui, et al.. (2020). Nuclear cGAS Functions Non-canonically to Enhance Antiviral Immunity via Recruiting Methyltransferase Prmt5. Cell Reports. 33(10). 108490–108490. 67 indexed citations
8.
Du, Yi, Katsuya Nakai, Ming Ding, et al.. (2017). EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer. Oncogene. 37(2). 208–217. 83 indexed citations
9.
Ding, Ming, Richard K. Bruick, & Yonghao Yu. (2016). Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling. Nature Cell Biology. 18(3). 319–327. 57 indexed citations
10.
Xiang, Siheng, Masato Kato, Leeju C. Wu, et al.. (2015). The LC Domain of hnRNPA2 Adopts Similar Conformations in Hydrogel Polymers, Liquid-like Droplets, and Nuclei. Cell. 163(4). 829–839. 226 indexed citations
11.
Wu, Ying, et al.. (2012). The impact of E-cadherin expression on non-small cell lung cancer survival: a meta-analysis. Molecular Biology Reports. 39(10). 9621–9628. 28 indexed citations
12.
Zhu, Xi, Ming Ding, Meilan Yu, et al.. (2010). Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis. BMC Cancer. 10(1). 290–290. 54 indexed citations
13.
Ding, Ming, James J. Potter, Xiaopu Liu, Michael Torbenson, & Esteban Mezey. (2009). Selenium Supplementation Decreases Hepatic Fibrosis in Mice After Chronic Carbon Tetrachloride Administration. Biological Trace Element Research. 133(1). 83–97. 38 indexed citations
14.
Ding, Ming, et al.. (2009). Identification, expression, and characterization of the highly conserved d-xylose isomerase in animals. Acta Biochimica et Biophysica Sinica. 41(2). 116–122. 5 indexed citations
15.
Guo, Rui, Ming Ding, Siliang Zhang, Gen-Jun Xu, & Fukun Zhao. (2008). Expression and characterization of two secreted His<sub>6</sub>-tagged endo-β-1,4-glucanases from the mollusc <italic>Ampullaria crossean</italic> in <italic>Pichia pastoris</italic>. Acta Biochimica et Biophysica Sinica. 40(5). 419–425. 11 indexed citations
16.
Ding, Ming, et al.. (2008). The N-terminal cellulose-binding domain of EGXA increases thermal stability of xylanase and changes its specific activities on different substrates. Acta Biochimica et Biophysica Sinica. 40(11). 949–954. 13 indexed citations
17.
Guo, Rui, Ming Ding, Siliang Zhang, Gen-Jun Xu, & Fukun Zhao. (2007). Molecular cloning and characterization of two novel cellulase genes from the mollusc Ampullaria crossean. Journal of Comparative Physiology B. 178(2). 209–215. 46 indexed citations
18.
Xu, Jin, Jingjing Liu, Peng Duan, et al.. (2005). A synthetic gonadotropin-releasing hormone (GnRH) vaccine for control of fertility and hormone dependent diseases without any adjuvant. Vaccine. 23(40). 4834–4843. 28 indexed citations
19.
Li, Yanhong, Rui Guo, Ming Ding, et al.. (2005). Purification and Characterization of Two Endo-β-1,4-glucanases from Mollusca, <italic>Ampullaria crossean</italic>. Acta Biochimica et Biophysica Sinica. 37(10). 702–708. 22 indexed citations
20.
Gao, Guanghua, Jixun Dai, Ming Ding, et al.. (1999). Studies on solution NMR structure of brazzein. Science in China Series C Life Sciences. 42(4). 409–419. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jörg Piontek Breakdown of academic impact, for papers by Vincent S. Tagliabracci Breakdown of academic impact, for papers by Doo‐Sik Kim Breakdown of academic impact, for papers by Eugene W. Krueger Breakdown of academic impact, for papers by Nazanine Modjtahedi Breakdown of academic impact, for papers by Feng Gu Breakdown of academic impact, for papers by Carol Murphy Breakdown of academic impact, for papers by Fred Levine Breakdown of academic impact, for papers by Ralph Bradshaw Breakdown of academic impact, for papers by Yuanyuan Ma
Rankless by CCL
2026